News + Updates
Powerful websites to share your science story: from team and research to publications and impact.
Search
Search results
2298 results found
Hemodynamic and arrhythmogenic effects of cocaine in hypertensive individuals.
Secemsky, Eric, David Lange, David D Waters, Nora F Goldschlager, and Priscilla Y Hsue. 2011. “Hemodynamic and Arrhythmogenic Effects of Cocaine in Hypertensive Individuals.”. Journal of Clinical Hypertension (Greenwich, Conn.) 13 (10): 744-9.
Mitral Annular and Coronary Artery Calcification Are Associated with Mortality in HIV-Infected Individuals.
Lange, David C, David Glidden, Eric A Secemsky, Karen Ordovas, Steven G Deeks, Jeffrey N Martin, Ann F Bolger, and Priscilla Y Hsue. 2015. “Mitral Annular and Coronary Artery Calcification Are Associated With Mortality in HIV-Infected Individuals.”. PloS One 10 (7): e0130592.
Public reporting in cardiovascular medicine: accountability, unintended consequences, and promise for improvement.
Wasfy, Jason H, William B Borden, Eric A Secemsky, James M McCabe, and Robert W Yeh. 2015. “Public Reporting in Cardiovascular Medicine: Accountability, Unintended Consequences, and Promise for Improvement.”. Circulation 131 (17): 1518-27.
Target Vessel Revascularization and Territory of Myocardial Ischemia in Patients With Chronic Total Occlusions.
Secemsky, Eric A, Robert Gallagher, James Harkness, Eugene Pomerantsev, Henry Gewirtz, Farouc A Jaffer, and Robert W Yeh. 2017. “Target Vessel Revascularization and Territory of Myocardial Ischemia in Patients With Chronic Total Occlusions.”. Journal of the American College of Cardiology 70 (9): 1196-97.
Reply: Duration of the Double Antiplatelet Therapy in Patients With Coronary and Peripheral Arterial Disease: The Key Might Be in the Type of Drug.
Secemsky, Eric A, Robert W Yeh, Laura Mauri, and DAPT Study Investigators. 2017. “Reply: Duration of the Double Antiplatelet Therapy in Patients With Coronary and Peripheral Arterial Disease: The Key Might Be in the Type of Drug.”. JACC. Cardiovascular Interventions 10 (14): 1468-69.
Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus Heparin: A Report From the National Cardiovascular Data Registry.
Jovin, Ion S, Rachit M Shah, Dhavalkumar B Patel, Sunil Rao V, Dmitri Baklanov V, Issam Moussa, Kevin F Kennedy, et al. 2017. “Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus Heparin: A Report From the National Cardiovascular Data Registry.”. JACC. Cardiovascular Interventions 10 (11): 1102-11.
Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study.
Secemsky, Eric A, Robert W Yeh, Dean J Kereiakes, Donald E Cutlip, David J Cohen, Gabriel Steg, Christopher P Cannon, et al. 2017. “Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study.”. JAMA Cardiology 2 (5): 478-87.
Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States.
Secemsky, Eric A, Ajay Kirtane, Sripal Bangalore, Ion S Jovin, Rachit M Shah, Enrico G Ferro, Neil J Wimmer, et al. 2016. “Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States.”. JACC. Cardiovascular Interventions 9 (23): 2376-86.